Change of Name

Recorded: 2024-08-12 Pages: 18

Assignor

ARROWHEAD RESEARCH CORPORATION

Executed: 2016-04-05

Assignee

ARROWHEAD PHARMACEUTICALS, INC.

225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101

Covered Properties (3)

Rnai-Mediated Inhibition of H1F1A for Treatment of Ocular Angiogenesis

Patent: 7,981,870 →

Application: 12/706,014 →

Publication: US 2010/0144844

Rnai-Mediated Inhibition of HIF1A for Treatment of Ocular Angiogenesis

Patent: 8,471,000 →

Application: 13/474,405 →

Publication: US 2012/0245217

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Patent: 8,940,887 →

Application: 13/904,431 →

Publication: US 2013/0245098

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.